A molecular and genetic view of human renal and urinary tract malformations

Kidney International

Volumn 58, Issue 2, 2000, Pages 500-512

  Woolf, A S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Congenital renal parenchymal defects; Embryonic metanephros; Kidney malformation; Primary vesicoureteric reflux; Renal mesenchyme

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; MESSENGER RNA; TRANSCRIPTION FACTOR;

CHROMOSOME 6; CHRONIC KIDNEY FAILURE; COLOBOMA; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; HUMAN; KALLMANN SYNDROME; KIDNEY AGENESIS; KIDNEY MALFORMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; URINARY TRACT MALFORMATION; VESICOURETERAL REFLUX;

EID: 0033860405     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00196.x     Document Type: Article

References (139)

1. Mechanisms of organogenetic tissue interaction
2. Inductive tissue interactions, cell signaling, and the control of kidney organogenesis
3. The pathogenesis of renal dysplasia. II. The significance of lateral and medial ectopy of the ureteric orifice
4. Position and configuration of the ureteral orifice and its relationship to renal scarring in adults
5. Molecular and cellular pathophysiology of obstructive nephropathy
6. Obstruction of the fetal urinary tract
7. Fetal nephron mass: Its control and deficit
8. Vesicoureteric reflux in the newborn: Relationship to fetal renal pelvic diameter
9. Congenitally small kidneys with reflux as a common cause of nephropathy in boys
10. The characteristics of primary vesico-ureteric reflux in male and female infants with pre-natal hydronephrosis
11. Prospective study of outcome in antenatally diagnosed renal pelvis dilatation
12. Renal replacement therapy for end-stage renal failure before 2 years of age
13. Progression to end-stage renal disease in children with posterior urethral valves
14. Advances in the cell biology and genetics of human kidney malformations
15. Malformations of kidney and urinary tract in Common chromosomal aberrations. I. Clinical studies
16. Three cases of dup(10p)/del(10q) syndrome resulting from maternal pericentric inversion
17. Renal agenesis and uteropelvic junction obstruction in an infant with Turner syndrome
18. WT-1 is required for early kidney development
19. Pax-2 controls multiple steps of urogenital development
20. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
21. Function of the retinoic acid receptors during development
22. Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11
23. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor
24. The PAX2 transcription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations
25. Kidney and retinal defects (Krd), a transgene-induced mutation with a deletion of mouse chromosome 19 that includes the Pax2 locus
26. The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye and kidney
27. Mutations of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux
28. Mutation of PAX2 in two siblings with renal-coloboma syndrome
29. Further delineation of the renal-coloboma syndrome in patients with remarkable variability of phenotype and identical PAX2 mutations
30. Localisation of a 10q breakpoint within the PAX2 gene in a patients with a de novo t(10;13) translocation and optic nerve coloboma-renal syndrome
31. Familial occurrence of hereditary renal adysplasia with Mullerian anomalies
32. Solitary kidney and bicornuate uterus in mother and child
33. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor
34. A rodent model for Wilms' tumors: Embryonal kidney neoplasms induced by N-nitroso-N'-methylurea
35. Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides
36. The oncogenic potential of Pax genes
37. Loss of p53 function through PAX-mediated transcriptional repression
38. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities
39. Reduced Pax2 gene dosage increases apoptosis and slows progression of renal cystic disease
40. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair
41. Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice
42. Epithelial galectin-3 during human nephrogenesis and childhood cystic diseases
43. Renal cell carcinoma in multicystic dysplastic kidney
44. Nodular renal blastema, renal dysplasia and duplicated collecting systems
45. Wilms' tumor and multicystic dysplastic kidney disease
46. Deregulation of cell survival in cystic and dysplastic renal development
47. Decreased bcl-2 expression in segmental renal dysplasia suggests a role in its morphogenesis
48. Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys
49. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and atonal path-finding molecules
50. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules
51. Luteinizing hormone-releasing hormone-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome
52. Identification of olfactory dysfunction in carriers of X-linked Kallmann's syndrome
53. The genetic aspects of primary eunuchoidism
54. X chromosome-linked Kallmann syndrome: Stop mutations validate the candidate gene
55. Unilateral renal aplasia in X-linked Kallmann's syndrome
56. Familial Kallmann syndrome with unilateral renal aplasia
57. Renal abnormalities in patients with Kallmann syndrome
58. An autopsy case of Kallmann's syndrome
59. Kallmann syndrome in two sisters with other developmental anomalies also affecting their father
60. Proteinuria, hypertension and chronic renal failure in X-linked Kallmann's syndrome, a defined genetic cause of solitary functioning kidney
61. Nephron mass as a risk factor for progression of renal disease
62. Focal and segmental glomerulosclerosis and proteinuria associated with unilateral renal agenesis
63. Prognosis of patients with unilateral renal agenesis
64. Focal glomerular sclerotic lesions in a patient with unilateral oligomeganephronia and agenesis of the contralateral kidney: A case report
65. Oligomeganephronic renal hypoplasia
66. Initial characterisation of anosmin-1, a putative extracellular matrix protein synthesised by definite neuronal cell populations in the central nervous system
67. Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner
68. KAL, a gene mutated in Kallmann's syndrome, is expressed in the first trimester of human development
69. Anosmin-1 is a regionally restricted component of basement membranes and interstitial matrices during organogenesis: Implications for the developmental anomalies of X chroraosome-linked Kallmann syndrome
70. Role of laminin A chain in the development of epithelial cell polarity
71. The renal glomerulus of mice lacking s-laminin/laminin β2: Nephrosis despite molecular compensation by laminin β1
72. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis
73. Integrin α8β1 is critically important for epithelial-mesenchymal interactions during kidney development
74. Denys-Drash syndrome: Relating a clinical disorder to alterations in the tumor suppressor gene WT1
75. Donor splice-site mutations in WT1 are responsible for Frasier syndrome
76. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease: A contiguous gene syndrome
77. X-linked Kallmann syndrome and renal agenesis occurring together and independently in a large Australian family
78. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1
79. Inherited renal cell carcinoma
80. Dissociation of glomerular hypertrophy, cell proliferation and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number
81. Familial renal agenesis and total dysplasia
82. Familial nature of congenital absence and severe dysgenesis of both kidneys
83. Familial unilateral renal agenesis and focal and segmental glomerulosclerosis
84. Dominantly inherited renal adysplasia
85. Familial renal adysplasia
86. Multicystic kidney in siblings
87. Multicystic renal Dysplasia in two consecutive male infants
88. Oligomeganephronic renal hypoplasia in two siblings
89. Renal tubular dysgenesis with calvarial hypoplasia: Report of two additional cases and review
90. Evidence for genetic heterogeneity in hereditary hydronephrosis caused by pelviureteric dunction obstruction, with one locus assigned to chromosome 6p
91. Vesicoureteric reflux: All in the genes?
92. Unravelling the genetics of vesicoureteric reflux: A common familial disorder
93. Posterior urethral valves in siblings
94. Familial pelviureteric junction hydronephrosis and its association with a duplex pelvicalyceal system and vesicoureteric reflux: A family study
95. Infundibulopelvic stenosis, multicystic kidney, and calyectasis in a kindred: Clinical observations and genetic analysis
96. Renal multicystic dysplasia: An occasional manifestation of the hereditary renal adysplasia syndrome
97. Genetic locus on chromosome 6p for multicystic renal dysplasia, pelvi-ureteral junction stenosis, and vesicoureteral reflux
98. HLA linkage with familial vesicoureteric reflux and familial pelviureteric junction obstruction
99. Structure, sequence, and chromosome 19 localisation of human USF2 and its rearrangement in a patient with multicystic renal dysplasia
100. Rearrangement of the human CDC5L gene by a t(6;19)(p21;q13.1) in a patient with multicystic renal dysplasia
101. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes
102. Angiotensin II regulates nephrogenesis and renal vascular development
103. Glomerular number and size following chronic angiotensin II blockade in the postnatal rat
104. Angiotensin induces the urinary peristaltic machinery during the perinatal period
105. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men
106. Angiotensin II type 2 receptor mediates programmed cell death
107. Genetic deletion of AT2 receptor antagonises angiotensin II-induced apoptosis in fibroblast of the mouse embryo
108. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor
109. Angiotensin type 2 receptor is important in the normal development of the ureter
110. Angiotensin-converting enzyme inhibitor fetopathy
111. Teratogen update: Angiotensin-converting enzyme inhibitors
112. Recognition and management of angiotensin converting enzyme fetopathy
113. Renal tubular dysgenesis with microcephaly
114. The etiology of hypertension in nonrenovascular unilateral renal disease: Two cases on renin induced hypertension in congenital renal dysplasia
115. Unilateral multicystic dysplastic kidney: The case for nephrectomy
116. Vesico-ureteric reflux and reflux nephropathy
117. High pressure sterile vesicoureteral reflux and renal scarring: An experimental study in the pig and minipig
118. Renal hypoplasia and postnatal acquired cortical loss in children with vesicoureteric reflux
119. Reflux nephropathy in children submitted to nephrectomy: A clinicopathological study
120. The long-term results of prospective sibling reflux screening
121. The transmission of vesicoureteric reflux from parent to child
122. Screening of newborn babies for familial ureteric reflux
123. Vesicoureteral reflux: A segregation analysis
124. Primary, non-syndromic vesicoureteric reflux and is genetically heterogeneous with a locus on chromosome 1
125. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
126. Angiotensin II, type 2 receptor in the development of vesico-ureteric reflux
127. Absence of PAX2 gene mutations in patients with primary vesicoureteric reflux
128. Polymorphisms in angiotensin converting enzyme gene and reflux nephropathy: A genetic predisposition to scar formation?
129. Potential risk factors associated with progressive renal damage in childhood urological diseases: The role of angiotensin-converting enzyme gene polymorphism